Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
12 years and older unless not permitted by local regulations; in that case 18 years old and older
Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 1
Histologically confirmed Stage III (unresectable) or Stage IV melanoma, per the American Joint Committee on Cancer (AJCC) Staging Manual (8th edition)
Treatment-naïve participants (no prior systemic anticancer therapy for unresectable or metastatic melanoma)
Measurable disease per RECIST v1.1
You may not be if
Active brain metastases or leptomeningeal metastases
Uveal or ocular melanoma
Participants with active, known, or suspected autoimmune disease
Prior malignancy active within the previous 3 years except for locally curable cancers that have been apparently cured
Clareo Health | An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma
